Log In
Print
BCIQ
Print
Print this Print this
 

Seprehvir (HSV1716)

  Manage Alerts
Collapse Summary General Information
Company Virttu Biologics Ltd.
DescriptionMutant HSV type 1 with a deletion in the RL1 gene
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today